These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Epstein-Barr virus infection in non-carcinomatous gastric epithelium. Yanai H; Takada K; Shimizu N; Mizugaki Y; Tada M; Okita K J Pathol; 1997 Nov; 183(3):293-8. PubMed ID: 9422984 [TBL] [Abstract][Full Text] [Related]
43. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues. Takasaka N; Tajima M; Okinaga K; Satoh Y; Hoshikawa Y; Katsumoto T; Kurata T; Sairenji T Virology; 1998 Aug; 247(2):152-9. PubMed ID: 9705908 [TBL] [Abstract][Full Text] [Related]
44. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Kelly G; Bell A; Rickinson A Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084 [TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment. Cohen M; De Matteo E; Narbaitz M; CarreƱo FA; Preciado MV; Chabay PA Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474 [TBL] [Abstract][Full Text] [Related]
46. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W mBio; 2019 Sep; 10(5):. PubMed ID: 31530670 [TBL] [Abstract][Full Text] [Related]
47. Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations. Anagnostopoulos I; Hummel M; Kaudewitz P; Korbjuhn P; Leoncini L; Stein H Br J Dermatol; 1996 Feb; 134(2):276-81. PubMed ID: 8746341 [TBL] [Abstract][Full Text] [Related]
48. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Chiang AK; Tao Q; Srivastava G; Ho FC Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467 [TBL] [Abstract][Full Text] [Related]
49. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Delecluse HJ; Kremmer E; Rouault JP; Cour C; Bornkamm G; Berger F Am J Pathol; 1995 May; 146(5):1113-20. PubMed ID: 7747805 [TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus infection in sarcomatoid renal cell carcinoma tissues. Kim KH; Han EM; Lee ES; Park HS; Kim I; Kim YS BJU Int; 2005 Sep; 96(4):547-52. PubMed ID: 16104908 [TBL] [Abstract][Full Text] [Related]
51. [Studies on tissue distribution and expression of Epstein-Barr virus using polymerase chain reaction]. Oikawa O Hokkaido Igaku Zasshi; 1995 Sep; 70(5):729-42. PubMed ID: 8543279 [TBL] [Abstract][Full Text] [Related]
52. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239 [TBL] [Abstract][Full Text] [Related]
53. In situ detection of Epstein-Barr virus and phenotype determination of EBV-infected cells. Niedobitek G; Herbst H Methods Mol Biol; 2006; 326():115-37. PubMed ID: 16780197 [TBL] [Abstract][Full Text] [Related]
54. [In situ detection of Epstein-Barr virus in the non-neoplastic gastric glands and infiltrated lymphocytes]. Sasaki Y; Hayashi K; Suzuki T; Toyoshima A; Teragawa M; Gouda S; Amimoto K; Matsui S; Yamane Y; Chen HL; Ohara N; Teramoto N; Akagi T Rinsho Byori; 1996 Dec; 44(12):1196-200. PubMed ID: 8990940 [TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. Niedobitek G; Agathanggelou A; Nicholls JM Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600 [TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus and carcinomas. Expression of the viral genome in an undifferentiated gastric carcinoma. Niedobitek G; Herbst H; Young LS; Rowe M; Dienemann D; Germer C; Stein H Diagn Mol Pathol; 1992 Jun; 1(2):103-8. PubMed ID: 1342957 [TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus can infect rabbits by the intranasal or peroral route: an animal model for natural primary EBV infection in humans. Okuno K; Takashima K; Kanai K; Ohashi M; Hyuga R; Sugihara H; Kuwamoto S; Kato M; Sano H; Sairenji T; Kanzaki S; Hayashi K J Med Virol; 2010 May; 82(6):977-86. PubMed ID: 20419811 [TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. Niedobitek G; Young LS; Lau R; Brooks L; Greenspan D; Greenspan JS; Rickinson AB J Gen Virol; 1991 Dec; 72 ( Pt 12)():3035-46. PubMed ID: 1662695 [TBL] [Abstract][Full Text] [Related]
60. [Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas]. Furukawa M; Nagayama I; Murono S; Takeshita H; Nishimura T; Yoshizaki T Rinsho Byori; 1996 Sep; 44(9):832-7. PubMed ID: 8911067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]